8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1561 | 123C4 | Ephrin Receptor | |
123C4 is a novel, potent, and selective agonist of the tyrosine kinase EphA4 receptor. | |||
T4344 | ALW-II-41-27 | Eph receptor tyrosine kinase inhibitor | Ephrin Receptor |
ALW-II-41-27 (Eph receptor tyrosine kinase inhibitor), an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy. | |||
T19487 | NVP-BHG712 isomer | Ephrin Receptor | |
NVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4. | |||
T6348 | NVP-BHG712 | Raf , Bcr-Abl , Src , Ephrin Receptor | |
NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respecti... | |||
T5451 | Eph inhibitor 2 | Ehp-inhibitor-1 | Ephrin Receptor |
Eph inhibitor 2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors. | |||
T3476 | JI-101 | CGI-1842,JI 101 | VEGFR , PDGFR , Ephrin Receptor |
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4). | |||
TQ0166 | Tesevatinib | KD-019,XL-647,EXEL-7647 | EGFR , VEGFR , FLT , Ephrin Receptor |
Tesevatinib (XL-647) is an orally available, multi-target tyrosine kinase inhibitor (IC50s: 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR, ErbB2, KDR, Flt4, and EphB4). | |||
T38511 | AWL-II-38.3 | Ephrin Receptor | |
AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show significant cellular activity against Src-family kinases or... |